To the full analysis
Asymchem Laboratories (Tianjin) stock: growth
002821.SZAsymchem Laboratories (Tianjin) reported $1B in revenue for fiscal 2025, up 14.9% on the prior year, up 16.3% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
22.1%
per year from 2011 to 2025, per share 19.1%
Earnings (Annual rate)
22.6%
per year from 2011 to 2025, per share 19.5%
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2011 | |
|---|---|---|---|
| Revenue | 16.3% | 23.2% | 22.1% |
| Revenue per share | 14.1% | 18.9% | 19.1% |
| Earnings | 9.5% | 22.1% | 22.6% |
| Earnings per share | 7.4% | 17.9% | 19.5% |
| Free cash flow | no data | 0.3% | no data |
| Free cash flow per share | no data | −3.2% | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2011 | $60.84M | $9.8M | −$16.71M |
| 2012 | $63.64M | $9.04M | −$14.66M |
| 2013 | $81.39M | $11.21M | $2.13M |
| 2014 | $107.41M | $15.27M | $8.93M |
| 2015 | $124.56M | $23.03M | $20.06M |
| 2016 | $165.44M | $37.9M | $6.3M |
| 2017 | $213.4M | $51.18M | −$16.05M |
| 2018 | $275.17M | $64.23M | −$19.21M |
| 2019 | $368.91M | $83.06M | $13.51M |
| 2020 | $470.4M | $107.94M | −$66.83M |
| 2021 | $694.65M | $160.35M | −$231.93M |
| 2022 | $1.53B | $495.13M | $170.4M |
| 2023 | $1.17B | $340.24M | $346.14M |
| 2024 | $870.49M | $142.31M | $18.64M |
| 2025 | $1B | $169.84M | $20.58M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = CN¥6.6683)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 13 Dec 2024)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.